Scavenger receptor-BI is a receptor for lipoprotein(a)

Journal of Lipid Research

Volumn 54, Issue 9, 2013, Pages 2450-2457

  Yang, Xiao Ping ^a   Amar, Marcelo J ^b   Vaisman, Boris ^b   Bocharov, Alexander V ^c   Vishnyakova, Tatyana G ^c   Freeman, Lita A ^b   Kurlander, Roger J ^d   Patterson, Amy P ^c   Becker, Lewis C ^a   Remaley, Alan T ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Apolipoprotein(a); Atherosclerosis; Lipoprotein receptors; Oxidized lipids; Selective uptake

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN B; IODINE 125; LIPOPROTEIN A; SCAVENGER RECEPTOR BI;

ANIMAL EXPERIMENT; ARTICLE; CELL STRAIN HEK293; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HELA CELL; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; INTERNALIZATION; LIPID TRANSPORT; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSGENIC MOUSE;

APOLIPOPROTEIN(A); ATHEROSCLEROSIS; LIPOPROTEIN RECEPTORS; OXIDIZED LIPIDS; SELECTIVE UPTAKE;

ANIMALS; ANTIGENS, CD36; HEK293 CELLS; HUMANS; LIPOPROTEIN(A); MICE; PROTEIN TRANSPORT;

EID: 84883192066     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M038877     Document Type: Article

References (34)

1. Rhainds, D., and L. Brissette. 2004. The role of scavenger receptor class B type I (SR-BI) in lipid trafficking. Defining the rules for lipid traders. Int. J. Biochem. Cell Biol. 36: 39-77.
2. Acton, S., A. Rigotti, K. T. Landschulz, S. Xu, H. H. Hobbs, and M. Krieger. 1996. Identification of scavenger receptor SR-BI as a high density lipoprotein receptor. Science. 271: 518-520.
3. Murao, K., V. Terpstra, S. R. Green, N. Kondratenko, D. Steinberg, and O. Quehenberger. 1997. Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes. J. Biol. Chem. 272: 17551-17557.
4. Wang, N., T. Arai, Y. Ji, F. Rinninger, and A. R. Tall. 1998. Liverspecific overexpression of scavenger receptor BI decreases levels of very low density lipoprotein ApoB, low density lipoprotein ApoB, and high density lipoprotein in transgenic mice. J. Biol. Chem. 273: 32920-32926.
5. Rader, D. J., E. T. Alexander, G. L. Weibel, J. Billheimer, and G. H. Rothblat. 2009. The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis. J. Lipid Res. 50 ( Suppl. ): S189-S194.
6. Utermann, G. 1989. The mysteries of lipoprotein(a). Science. 246: 904-910.
7. Gavish, D., N. Azrolan, and J. L. Breslow. 1989. Plasma lp(a) concentration is inversely correlated with the ratio of Kringle IV/ Kringle V encoding domains in the apo(a) gene. J. Clin. Invest. 84: 2021-2027.
8. Lanktree, M. B., S. S. Anand, S. Yusuf, and R. A. Hegele. 2010. Comprehensive analysis of genomic variation in the LPA locus and its relationship to plasma lipoprotein(a) in South Asians, Chinese, and European Caucasians. Circ. Cardiovasc. Genet. 3: 39-46.
9. Trommsdorff, M., S. Kochl, A. Lingenhel, F. Kronenberg, R. Delport, H. Vermaak, L. Lemming, I. C. Klausen, O. Faergeman, G. Utermann, et al. 1995. A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J. Clin. Invest. 96: 150-157.
10. Jenner, J. L., L. J. Seman, J. S. Millar, S. Lamon-Fava, F. K. Welty, G. G. Dolnikowski, S. M. Marcovina, A. H. Lichtenstein, P. H. Barrett, C. deLuca, et al. 2005. The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism. 54: 361-369.
11. Rader, D. J., W. A. Mann, W. Cain, H. G. Kraft, D. Usher, L. A. Zech, J. M. Hoeg, J. Davignon, P. Lupien, M. Grossman, et al. 1995. The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans. J. Clin. Invest. 95: 1403-1408.
12. Reblin, T., A. Niemeier, N. Meyer, T. E. Willnow, F. Kronenberg, H. Dieplinger, H. Greten, and U. Beisiegel. 1997. Cellular uptake of lipoprotein[a] by mouse embryonic fibroblasts via the LDL receptor and the LDL receptor-related protein. J. Lipid Res. 38: 2103-2110.
13. Argraves, K. M., K. F. Kozarsky, J. T. Fallon, P. C. Harpel, and D. K. Strickland. 1997. The atherogenic lipoprotein Lp(a) is internalized and degraded in a process mediated by the VLDL receptor. J. Clin. Invest. 100: 2170-2181.
14. Vishnyakova, T. G., A. V. Bocharov, I. N. Baranova, Z. Chen, A. T. Remaley, G. Csako, T. L. Eggerman, and A. P. Patterson. 2003. Binding and internalization of lipopolysaccharide by Cla-1, a human orthologue of rodent scavenger receptor B1. J. Biol. Chem. 278: 22771-22780.
15. Yang, X. P., S. Mattagajasingh, S. Su, G. Chen, Z. Cai, K. Fox-Talbot, K. Irani, and L. C. Becker. 2007. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway. Circ. Res. 101: 1001-1008.
16. Fless, G. M., and M. L. Snyder. 1996. Quantitation of lipoprotein (a) after lysine-sepharose chromatography and density gradient centrifugation. Methods Enzymol. 263: 238-251.
17. Stein, Y., Y. Dabach, G. Hollander, G. Halperin, and O. Stein. 1983. Metabolism of HDL-cholesteryl ester in the rat, studied with a nonhydrolyzable analog, cholesteryl linoleyl ether. Biochim. Biophys. Acta. 752: 98-105.
18. Shamburek, R. D., P. G. Pentchev, L. A. Zech, J. Blanchette-Mackie, E. D. Carstea, J. M. VandenBroek, P. S. Cooper, E. B. Neufeld, R. D. Phair, H. B. Brewer, Jr., et al. 1997. Intracellular trafficking of the free cholesterol derived from LDL cholesteryl ester is defective in vivo in Niemann-Pick C disease: insights on normal metabolism of HDL and LDL gained from the NP-C mutation. J. Lipid Res. 38: 2422-2435.
19. Redgrave, T. G., D. C. Roberts, and C. E. West. 1975. Separation of plasma lipoproteins by density-gradient ultracentrifugation. Anal. Biochem. 65: 42-49.
20. Gotto, A. M., and H. J. Pownall. 2003. Manual of Lipid Disorders: Reducing the Risk for Coronary Disease. Lippincott, Williams and Wilkins, Philadelphia, PA.
21. Reaven, E., L. Tsai, and S. Azhar. 1996. Intracellular events in the "selective" transport of lipoprotein-derived cholesteryl esters. J. Biol. Chem. 271: 16208-16217.
22. Pitas, R. E., T. L. Innerarity, J. N. Weinstein, and R. W. Mahley. 1981. Acetoacetylated lipoproteins used to distinguish fibroblasts from macrophages in vitro by fluorescence microscopy. Arteriosclerosis. 1: 177-185.
23. Goldstein, J. L., S. K. Basu, and M. S. Brown. 1983. Receptormediated endocytosis of low-density lipoprotein in cultured cells. Methods Enzymol. 98: 241-260.
24. Fan, J., J. Wang, A. Bensadoun, S. J. Lauer, Q. Dang, R. W. Mahley, and J. M. Taylor. 1994. Overexpression of hepatic lipase in transgenic rabbits leads to a marked reduction of plasma high density lipoproteins and intermediate density lipoproteins. Proc. Natl. Acad. Sci. USA. 91: 8724-8728.
25. Vaisman, B. L., S. J. Demosky, J. A. Stonik, M. Ghias, C. L. Knapper, M. L. Sampson, C. Dai, S. J. Levine, and A. T. Remaley. 2012. Endothelial expression of human ABCA1 in mice increases plasma HDL cholesterol and reduces diet-induced atherosclerosis. J. Lipid Res. 53: 158-167.
26. Stockinger, W., E. Hengstschlager-Ottnad, S. Novak, A. Matus, M. Huttinger, J. Bauer, H. Lassmann, W. J. Schneider, and J. Nimpf. 1998. The low density lipoprotein receptor gene family. Differential expression of two alpha2-macroglobulin receptors in the brain. J. Biol. Chem. 273: 32213-32221.
27. Stangl, H., G. Cao, K. L. Wyne, and H. H. Hobbs. 1998. Scavenger receptor, class B, type I-dependent stimulation of cholesterol esterification by high density lipoproteins, low density lipoproteins, and nonlipoprotein cholesterol. J. Biol. Chem. 273: 31002-31008.
28. Stangl, H., M. Hyatt, and H. H. Hobbs. 1999. Transport of lipids from high and low density lipoproteins via scavenger receptor-BI. J. Biol. Chem. 274: 32692-32698.
29. Tabas, I., K. J. Williams, and J. Boren. 2007. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation. 116: 1832-1844.
30. Tsimikas, S., and J. L. Witztum. 2008. The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity. Curr. Opin. Lipidol. 19: 369-377.
31. Fluiter, K., W. Sattler, M. C. De Beer, P. M. Connell, D. R. van der Westhuyzen, and T. J. van Berkel. 1999. Scavenger receptor BI mediates the selective uptake of oxidized cholesterol esters by rat liver. J. Biol. Chem. 274: 8893-8899.
32. Jamieson, D. G., D. C. Usher, D. J. Rader, and E. Lavi. 1995. Apolipoprotein(a) deposition in atherosclerotic plaques of cerebral vessels. A potential role for endothelial cells in lesion formation. Am. J. Pathol. 147: 1567-1574.
33. Leonarduzzi, G., P. Gamba, S. Gargiulo, F. Biasi, and G. Poli. 2012. Inflammation-related gene expression by lipid oxidation-derived products in the progression of atherosclerosis. Free Radic. Biol. Med. 52: 19-34.
34. Kamstrup, P. R., A. Tybjaerg-Hansen, and B. G. Nordestgaard. 2013. Extreme lipoprotein(a) levels and improved cardiovascular risk prediction. J. Am. Coll. Cardiol. 61: 1146-1156.